Italian good news: Partnership Naples - Harvard for cancer research

May 22, 2014 641

WTI Magazine #31    2014 May, 22
Author :      Translation by:


A research protocol on the new frontiers of imaging in oncology with the prestigious Harvard Medical School. It is the latest addition to the process of internationalization of SDN Institute of Naples, which has become one of the most advanced diagnostic centers in Europe, thanks to large investments: on the one hand on research, with a team of more than 50 national dan international researchers; on the other hand on new technologies.

One example of this is that of PET-MRI. SDN Institute of Naples is the first in Italy, in South-Eastern Atlantic and the Mediterranean, to dispose of the innovative machinery Biographm MR, the tomograph body scanner capable of performing in a single examination both MRI and PET, hitherto executed in two different moments.

A true revolution of diagnostic imaging that allows you to accurately integrate structural images with functional images, indicating not only how the organ is done (MRI), but also how it works (PET). The result is a large increase in diagnostic accuracy in oncology, cardiology and neurology. In particular this method is much better in the study of tumors of the abdomen, of the genital sphere, of the liver and of the gastrointestinal tract, but is also useful to study the brain, both in tumor pathologies and in neurodegenerative diseases, such as the study of dementias.

Two days of study have been promoted within the framework of the scientific collaboration with the Harvard Medical School, based on double binary data exchange and researchers, dedicated just to the new frontiers of diagnostic PET-MRI.

It started Thursday, May 8 at 13:30 in the Conference Room of the Institute SDN with a conference devoted to the theme of "Correction of motion with the use of simultaneous PET-MRI". The guest of honor has been Chuan Huang, a researcher at Harvard Medical School and a great scholar of mathematical models applied in the evaluation and the refinement of diagnostic image quality, especially in PET-MRI, so as to receive in 2013 on these issues the Honorary Mention of "Young Investigator Award Symposium" from the annual meeting of the Society of Nuclear Medicine and Molecular Imaging.

Monday, May 19th at 14:30 the second conference was devoted to "State of the art and future of PET-MRI" with the presence of Bruce Rosen, a professor of radiology at Harvard Medical School and director of the "Center for Biomedical Imaging" at Massachusetts General Hospital. Rosen has illustrated some of the key findings of the research conducted in the field of oncology together by the researchers of SDN Institute of Naples and those of Harvard Medical School.

"One of the most important data of our studies – said Maria Antonia Di Palma, medical director of the SDN Institute - is the clear demonstration that the PET-MRI not only brings the visual benefit of a sharper and better image, but primarily it also brings a clinical benefit for the patient: to quote a figure, 18% of patients with oncological diseases performing a PET-MRI has modified their medical treatment in comparison to those decided after a PET-CT scan performed on the same day.

You may be interested